Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibrous stroma: Driver and passenger in cancer development. | Sci Signal | 2022 | 35258999 | PubTator, text mining | PubMed |
| Vaginal ALK-positive anaplastic large cell lymphoma treated with brentuximab vedotin: a case report and literature review. | Hematol Transfus Cell Ther | 2022 | 35256331 | PubTator, text mining | PubMed |
| Establishment of a patient-derived mucoepidermoid carcinoma cell line with the CRTC1-MAML2 fusion gene. | Mol Clin Oncol | 2022 | 35251626 | PubTator, text mining | PubMed |
| Multidrug-resistant Uro-associated Escherichia coli Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisation. | Eur Urol Open Sci | 2022 | 35243393 | PubTator, text mining | PubMed |
| Vulvar Leiomyosarcoma Masquerading as a Bartholin's Gland Cyst in an Adolescent. | Cureus | 2022 | 35242463 | PubTator, text mining | PubMed |
| Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease. | J Clin Invest | 2022 | 35239513 | PubTator, text mining | PubMed |
| HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. | Nat Commun | 2022 | 35228537 | PubTator, text mining | PubMed |
| Molecular Pathways in Peritoneal Mesothelioma: A Minireview of New Insights. | Front Oncol | 2022 | 35223506 | PubTator, text mining | PubMed |
| Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach. | Comput Math Methods Med | 2022 | 35222682 | PubTator, text mining | PubMed |
| Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy. | Front Pharmacol | 2022 | 35222040 | PubTator, text mining | PubMed |
| Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications. | EBioMedicine | 2022 | 35217407 | PubTator, text mining | PubMed |
| Simultaneous and ultra-sensitive SERS detection of SLPI and IL-18 for the assessment of donor kidney quality using black phosphorus/gold nanohybrids. | Opt Express | 2022 | 35209305 | PubTator, text mining | PubMed |
| Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer. | Cancers (Basel) | 2022 | 35205644 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. | Eur Respir Rev | 2022 | 35197267 | PubTator, text mining | PubMed |
| A 10-year retrospective study of lung cancer in Uganda. | BMC Cancer | 2022 | 35197014 | PubTator, text mining | PubMed |
| Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. | Respir Res | 2022 | 35189887 | PubTator, text mining | PubMed |
| Identification of Key Signaling Pathways and Genes in Eosinophilic Asthma and Neutrophilic Asthma by Weighted Gene Co-Expression Network Analysis. | Front Mol Biosci | 2022 | 35187081 | PubTator, text mining | PubMed |
| Plasmablastic lymphoma of the rectum: case report of a rare location and literature review. | J Surg Case Rep | 2022 | 35186254 | PubTator, text mining | PubMed |
| MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis. | Front Genet | 2022 | 35186034 | PubTator, text mining | PubMed |
| The challenging diagnosis of low-grade myofibroblastic sarcoma: A case report and literature update. | Oral Oncol | 2022 | 35183911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=42